Sign In
Buy FHTX
$3.64
+0.0100 (+0.275%)
At Close: Jun 03, 2026
Foghorn Therapeutics Appoints Ian Smith to its Board of Directors
07:00am, Wednesday, 28'th Apr 2021
CAMBRIDGE, Mass., April 28, 2021 (GLOBE NEWSWIRE) -- Foghorn Therapeutics Inc. (Nasdaq: FHTX), a company pioneering the discovery and development of a new class of medicines targeting genetically dete
Is a Surprise Coming for Foghorn Therapeutics (FHTX) This Earnings Season?
09:06am, Thursday, 01'st Apr 2021
Foghorn Therapeutics (FHTX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
FHTX Stock Price Increased 36.61%: Why It Happened
08:45am, Sunday, 21'st Mar 2021
The stock price of Foghorn Therapeutics Inc. (NASDAQ: FHTX) increased by 36.61% on March 19. This is why it happened.
UPDATE: Foghorn Therapeutics to Present Poster and Chair a Panel at the AACR Annual Meeting 2021
05:11pm, Thursday, 11'th Mar 2021
CAMBRIDGE, Mass., March 11, 2021 (GLOBE NEWSWIRE) -- Foghorn Therapeutics Inc. (Nasdaq: FHTX), a company pioneering the discovery and development of a new class of medicines targeting genetically dete
Foghorn Therapeutics to Present Poster and Chair a Panel and at the AACR Annual Meeting 2021
04:01pm, Thursday, 11'th Mar 2021
CAMBRIDGE, Mass., March 11, 2021 (GLOBE NEWSWIRE) -- Foghorn Therapeutics Inc. (Nasdaq: FHTX), a company pioneering the discovery and development of a new class of medicines targeting genetically dete
Foghorn Therapeutics to Participate in the 41st Cowen Annual Healthcare Conference
08:04am, Monday, 22'nd Feb 2021
CAMBRIDGE, Mass., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Foghorn Therapeutics Inc. (Nasdaq: FHTX), a company pioneering the discovery and development of a new class of medicines targeting genetically deter
U.S. IPO Week Ahead: 6 IPOs Squeeze In Before The Thanksgiving Holiday
01:53pm, Saturday, 14'th Nov 2020
US IPO market activity is picking back up ahead of the Thanksgiving holiday, with six IPOs scheduled to raise $3.4 billion in the week ahead. Biotech research product provider Maravai LifeSciences pla
